How to Buy Korro Bio Stock
Korro Bio Inc
Korro Bio, Inc. , a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc.
Korro Bio stock last closed at $31.14, down 0.67% from the previous day, and has decreased 23.79% in one year. It has overperformed other stocks in the Biotechnology industry by 0.26 percentage points. Korro Bio stock is currently +202.62% from its 52-week low of $10.29, and -68.22% from its 52-week high of $98.00.
At the moment, there are 9.39M shares of KRRO outstanding. The market cap of KRRO is $292.43M. In the past 24 hours, 96,000 KRRO shares were traded.
How to Buy Korro Bio Stock
Not sure how to invest in Korro Bio stock? Here's how.
- Decide where to buy Korro Bio stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Korro Bio stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your investment account: Choose your method of payment and add your details.
- Research Korro Bio stock: The Korro Bio ticker symbol is KRRO. Is Korro Bio stock a good investment? Should you buy shares of KRRO? How do KRRO's underlying business fundamentals look? Do top analysts think Korro Bio is a good buy? Why has KRRO's stock price moved recently? (Hint: Our stock analysis website can help you figure out if KRRO is a good stock to buy).
- Make your KRRO trade: Decide if you will purchase KRRO shares at the current market price or use a limit order to purchase KRRO shares at a particular price.
- Track your investment in KRRO: Create a watchlist to key updates about your position in Korro Bio shares.
Step 1: Decide where to buy Korro Bio stock
You will need a brokerage account in order to access the NASDAQ market and buy KRRO stock.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal info so you are able to invest in KRRO stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start your new brokerage account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've filled out your info on the best stock investing app, you need to deposit funds:
Check out the tutorial below if you need help depositing funds into your new investment account.
Step 4: Research Korro Bio stock
Once you have figured out the best place to buy Korro Bio stock, it's critical to analyze their stock prior to buying, so you truly understand the risk as well as the opportunity.
Overview of key KRRO info
Korro Bio Fundamentals
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on KRRO's stock page.
What is the fair value of KRRO stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge KRRO's fair value.
Using relative valuations metrics:
- KRRO could be undervalued based on its P/B ratio of 2.54x, relative to Biotechnology industry P/B ratio of 4.68x
You can access additional valuation analysis on KRRO's stock here.
Is KRRO a healthy company?
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the KRRO balance sheet.
- KRRO has cash burn of 73859000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the KRRO balance sheet.
Negative Financial Indicators:
- Total KRRO debt is higher than 5 years ago, relative to shareholder equity.
- KRRO profit margin has gone down from N/A to -1,454.5% in the past year.
- KRRO has a relatively high debt to equity ratio of 0.57.
- KRRO has $96.36M in cash and short term investments. This is not sufficient to cover its annual cash burn of $73.86M.
Is it a good time to buy KRRO stock, according to Wall Street analysts?
Out of 6 Equities analysts who research KRRO, the consensus analyst rating on Korro Bio is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Latest KRRO Analyst Upgrades/Downgrades
Luca Issi, a top 30% analyst from RBC Capital maintains KRRO with a buy rating and lowers their KRRO price target from $105.00 to $95.00, on Mar 19, 2025.
You can dive deeper into what analysts are forecasting on the Korro Bio stock forecast page.
KRRO Momentum
KRRO Earnings
Last year, KRRO revenue was $6.28M. In the last five year, KRRO's revenue has increased by -32.47% per year. This was slower than the Biotechnology industry average of 67.22%.
You can analyze KRRO's earnings and revenue performance here.
Are KRRO executives and large shareholders buying or selling the stock?
Over the past year, executives and large shareholders at KRRO have bought as many shares as they have sold.
Vineet Agarwal, Chief Financial Officer of KRRO, was the latest KRRO insider to sell. They sold $56,000.00 worth of KRRO stock on Nov 11, 2024.
Dig into more about who owns KRRO stock here.
Does KRRO stock generate passive income?
No, Korro Bio doesn't provide an income stream by paying out dividends.
What do other investors have to say about KRRO?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your KRRO trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly sufficient. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a particular price, use a limit order.
Press the Open Trade button and your broker will execute the order.
If you need more assistance investing in stocks on eToro, click the helpful video below:
Step 6: Track your investment in KRRO
Now that you own some KRRO shares, you'll want to keep up with your new investment.
Put KRRO on a watchlist to keep track of your KRRO stock.
KRRO Feed
How to Buy Stock in Korro Bio
To summarize, here are the 6 steps to buy stock in Korro Bio:
- Decide where to buy Korro Bio stock
- Sign up for a brokerage account
- Fund your investment account
- Research Korro Bio stock
- Make your KRRO trade
- Track your investment in KRRO
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to monitor your new investment in Korro Bio, click below.
More Content You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.